Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 20, 2020 at 03:42 am
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 759.573 million compared to CNY 937.387 million a year ago. Operating income was CNY 37.999 million compared to operating loss of CNY 15.502 million a year ago. Net income was CNY 14.806 million compared to net loss of CNY 21.657 million a year ago. Basic earnings per share from continuing operations was CNY 0.0087 compared to basic loss per share from continuing operations of CNY 0.013 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.